ABSTRACT. Human milk was found to contain chemokinetic agents for human blood monocytes. The chemokinetic agents were whey proteins that were inactivated by heating at 56" C for 20 min or treatment with trypsin. Three peaks of chemokinetic activity less than 60 kD in size were found by gel filtration chromatography. The chemokinetic activity of each peak obtained by gel filtration was partially blocked by polyclonal rabbit antibodies to recombinant human tumor necrosis factor-a (TNF-a). TNF-a, or a protein that immunologically cross-reacted with it, was also detected in human milk by blockage of the cytotoxicity of human milk by anti-TNF-a. Such proteins or others that elicit the release of TNF-a from the target cells may be responsible for the enhanced motility of human milk macrophages, and it is possible that they may alter the immunologic or metabolic activities of the alimentary tract of the recipient infant. (Pediatu Res 25:629-633) Abbreviations mammary gland or that blood monocytes are modified in the mammary gland or by factors in human milk. Additional experimental observations supported those possibilities. In contrast to the lack of movement of neutrophils in human milk (12) (13) (14) , it was discovered that HMM spontaneously moved more rapidly than blood monocytes in a three-dimensional, type I collagen matrix (1 5).
mammary gland or that blood monocytes are modified in the mammary gland or by factors in human milk. Additional experimental observations supported those possibilities. In contrast to the lack of movement of neutrophils in human milk (12) (13) (14) , it was discovered that HMM spontaneously moved more rapidly than blood monocytes in a three-dimensional, type I collagen matrix (1 5) .
In this study, the genesis of the increased motility of human milk macrophages was investigated. We tested whether circulating systemic factors produced early in lactation, mammary gland tissue factors, or constituents in human milk up-regulated the motility of blood monocytes. The investigations revealed that human milk contains chemokinetic agents for blood monocytes and that one of those chemokinetic agents may be TNF-a or a protein that immunologically cross-reacts with it.
MATERIALS AND METHODS
Research subjects-leukocyte preparations. The use of human subjects in this iesearch was ~p p~o v e d by the Institutional Review HML, human milk leukocytes HMM, human milk macrophages Board of the Medical School. Donors were healthy adults or MEME, minimum essential medium, Eagle-modified healthy women who delivered full-term, normal infants vaginally PBML, peripheral blood mononuclear leukocytes 2 to 3 days before the collections (16) . Milk was collected into sterile polypropylene tubes by a low pressure electric pump TNF-a, tumor necrosis factor-a (Egnell, Inc., Cary, IL). Unfractionated HML were prepared as follows. Human colostrum was diluted 1 :4 in RMPI 1640 (Whittaker M.A. Bioproducts, Walkersville, MD) and centrifuged at 4000 x g for 10 min at 4" C. The cellular pellets were then Neutrophils, macrophages, and lymphocytes are found in hu-resuspended in RPMI 1640 to achieve a final concentration of 1 man milk during the first few months of lactation and the X lo7 leukocytes/ml. Heparinized venous blood was subjected numbers of macrophages in milk are particularly high as com-to Ficoll-Hypaque (Sigma Chemical Co., St. Louis, MO) density pared to the numbers of monocytes in human blood (1, 2) . gradients (17) to obtain mononuclear cell fractions (90% mono-HMM have been found to present antigens to T lymphocytes nuclear leukocytes) that were enriched for monocytes (20-25% (3); synthesize prostaglandin E2, lysozyme (4), and complement of total cells). Cell viability was tested by trypan blue exclusion. components, C2 and C4 (5); phagocytize microorganisms; pro-Monocytes/macrophages and neutrophils in blood or milk were duce toxic oxygen radicals; and kill ingested microorganisms (6-identified by staining for non-specific esterase or myeloperoxi-10). The role of these cells in the recipient infant remains, dase, respectively (18) . however, unclear. Certain in vitro studies indicate their in vivo Motility of cells in collagen gels. Type I collagen was prepared actions may be different from their counterparts in human blood. from rat tail tendons as previously described (19) . Tendons were Their ability to produce and release IL-1 in the resting state or stripped and solubilized in 3% (v/v) acetic acid at 4" C for 2 after stimulation with lipopolysaccharides was much less than days. After removing insoluble material by centrifugation, the that of human blood monocytes (1 1). Furthermore, the adher-collagen was precipitated by the addition of an equal volume of ence and directed movement of human milk macrophages are 20% (w/v) NaC1. The precipitate was pelleted by centrifugation not increased by chemoattractant agents (12) . This suggested that at 3000 X g for 1 h, washed, and resuspended in 3% acetic acid special populations of blood monocytes may be attracted to the to achieve a final concentration of 1.2 mg/ml. Then the solution was exhaustively dialyzed against distilled water with a pH of were counted at 6-9 h by inverted phase microscopy (Diavert, Leitz, FRG).
The types of cells that invaded the collagen gels were identified by cytochemical (18) or immunoperoxidase methods. For immunoperoxidase stains, gels were quick-frozen in precooled isopentane and embedded in O.C.T. Compound (Tissue Tek, Miles Scientific, Naperville, IL). After the tops were discarded, the gels were sliced horizontally into serial 4-p sections, air dried for 60 min and fixed in cold acetone (-20" C) for 10 min. After rehydration, they were incubated with one of the following primary antibodies to human antigens: sheep anti-cathepsin B (20) or anti-cathepsin-G (21) (ICN Immunobiologicals, Lisle, IL); mouse monoclonal anti-CD3, anti-CD5, anti-leu 7 (Becton Dickinson, Mountain View, CA), (Ortho Diagnostic System, Inc., Raritan, NJ); or mouse monoclonal anti-Mac-1 prepared in our laboratory. The preparations were exposed to either biotinylated rabbit anti-sheep IgG (Vector Laboratories, Burlingame, CA) or biotinylated sheep anti-mouse IgG (Cooper Biomedicals, Westchester, PA) (1:80). Then the reactions with streptavidin, biotinylated peroxidase complex (Amersham, Arlington Heights, IL) (1:500) were visualized by adding diaminobenzadine and hydrogen peroxide.
Fractionation of human colostrum. The aqueous phase of human colostrum was separated from the lipid phase by centrifugation at 4000 x g for 10 min at 4" C. Cells were excluded from the aqueous phase preparations by centrifuging them repeatedly at 300 x g for 5 min. The preparations were acidified to pH 4.0 with HCI and centrifuged at 4" C at 10,000 x g for 30 min to remove the caseins. The resultant acid soluble (whey) fraction was then reconstituted to the original volume and to pH 7.4. Acellular colostrum was fractionated by gel filtration chromatography. The specimens (1.5 ml) were pumped onto Sephacry1 200 (Pharmacia Fine Chemicals, Piscataway, NJ) using a 1.5 x 45 cm column with a flow rate of 60 ml/h and eluted with 50 mM PBS, pH 7.3. Protein concentrations in the effluent fractions were monitored by OD at 280 nm. Fractions (5 ml) were collected and tested for their abilities to enhance movement of peripheral blood monocytes in collagen gels. Enhancement of motility was expressed as a ratio between the number of cells in stimulated preparations divided by the number of cells in unstimulated preparations that migrated to 240 pM at 6-9 h.
SDS-PAGE: Western blotting.
The presence of TNF-a in the whey protein fraction of human milk was investigated by using SDS-PAGE and Western blotting (22) . Whey protein fractions were mixed with equal volumes of a non-reducing solution containing 13 mM Tris (pH 6.8) SDS (4.6%), and glycerol (20%, w/v) and boiled for 2 min. In some specimens, 2-mercaptoethan01 (5%; Sigma Chemical Co., St. Louis, MO.) was added. Then, SDS-PAGE was performed using 7.5-1 5% concentrations of polyacrylamide. Electrophoresis was carried out with a 20 mA current for 1 h and subsequently with a 30 mA current for 3.5 h. The SDS running buffer, pH 8.3, consisted of Tris (25 mM), glycine (191 mM), and SDS (0.1 %).
The polyacrylamide gel was soaked in a transfer buffer consisting of Tris (25 mM), glycine (192 mM), and 20% methanol for 1 h. The proteins were transferred electrophoretically onto a nitrocellulose strip by using a current of 100 mA overnight and 200 mA for an additional hour. The nitrocellulose sheets were blocked with 3% periodate treated BSA in 10 mM phosphate buffered saline for 1 h. The sheets were rinsed and incubated for 1 h with rabbit polyclonal antibodies to recombinant human TNF-a (1:250 in Tris-saline and 0.05% Tween) prepared according to a previously reported immunization schedule for generating antibodies to human IFN-y (23) or a second rabbit polyclonal antibody preparations to TNF-a that was obtained from a commercial source (Genzyme Corporation, Boston, MA). After washing, the preparation was incubated with goat antibodies to rabbit IgG conjugated to biotin (1:1500, v/v) for 1 h. The preparations were washed and incubated for 1 h with streptavidin conjugated with horseradish peroxidase (Calbiochem, La Jolla, CA). The sheets were then washed and developed with 4-chloro-1 -napthol.
Cytotoxicity assays. Cytotoxicity assays with human milk preparations or recombinant human TNF-a were performed as previously described (24) . Briefly, 5 x lo4 murine L-929 cells (American Type Culture Collection, Rockville, MD) in MEME, 10% FBS, penicillin (I 00 U), and streptomycin (1 00 pg/ml) were placed in each well of a 96-well microtiter plate (Costar, Cambridge, MA) and incubated at 37" C in an atmosphere of 4% C02. The medium was decanted after 24 h and replaced with MEME containing actinomycin D (5 pg/ml). The cells were then exposed to either unfractionated or fractionated whey proteins or recombinant human TNF-a. Negative controls for these experiments consisted of cells incubated only in the previously described medium. After 24 h of incubation or when the preparations exhibited maximal cytotoxicity, cells were stained with crystal violet (1 %) in methanol (20%) and photographed. Data presentation-statistical analyses. Group data concerning the number of cells that invaded 240 pM into the collagen gels were expressed as the mean + SD. Differences between the degree of movement of HMM and peripheral blood monocytes were tested by an unpaired Student's t-test, whereas the effects of acellular human colostrum, whey protein fractions, recombinant TNF-a, or antibodies to human TNF-a or human IL-1 upon the rate of movement of blood monocytes were tested by a paired Student's t test.
RESULTS

Motility of blood monocytes and human milk macrophages.
Blood monocytes from nine healthy adults and from nine healthy women in the first 2 days postpartum were investigated. For purposes of this presentation only the comparison of monocytes from healthy adults and HMM were shown because the rate of migration of blood monocytes from these two groups of subjects was similar. HMM moved far more rapidly than blood monocytes ( Fig. 1 A) .
Effect of human milk upon motility of blood monocytes.
The number of motile blood monocytes from normal adults or from women 2 days postpartum increased about 3-to 4-fold after they were exposed to acellular, defatted human colostrum (Fig. 1 B) . Moreover, the rates of movement of blood mononuclear leukocytes treated in vitro with human milk and of HMM were very similar ( Fig. 1 B) . The movement of blood mononuclear leukocytes was also enhanced by incubating those cells in human milk collected at 4-5 days or 1 mo of lactation (data not shown). The mononuclear blood leukocytes that invaded the gels after exposure to human milk were found to display markers for monocytes/macrophages (non-specific esterase, cathepsin B), but not for neutrophils (myeloperoxidase, cathepsin G) or lymphocytes (CD3, CD5, Leu 7). Physicochemical characteristics of chemokinetic agents in human milk. Chemokinetic activity for blood monocytes was detected in the whey proteins of milk (Fig. 2) . The activity was abolished by treating the whey proteins with trypsin or heating them at 56" C for 20 min (Fig. 2) . Concentrations of whey proteins as low as 2% significantly increased the number of blood monocytes that invaded the collagen gels.
The molecular size of the activators as estimated by centrifugation through dialysis membranes (Spectrum Medical Indus- performed, and at least five studies were conducted for each set of experiments. Monocytes/macrophages were enumerated at 240 fiM after 6-9 h of incubation. Since there were no differences in the movement of unstimulated blood monocytes from adults or postpartum women, those data were pooled for this presentation. Furthermore, since the effects of ACHM upon blood monocytes from adults and postpartum women were also similar, those data were also combined. The motility of HMM was much greater than that of untreated PBM ( p < 0.01), and the movement of PBM was significantly increased ( p < 0.0 1) when they were incubated in ACHM. Because of variations in this experimental system over time, data from the two separate data sets were not compared. tries, Inc., CA) was more than 10 kD. This was verified by Sephacryl200 (Pharmacia) gel chromatography. Three peaks of chemokinetic activity were found that corresponded approximately to 50-60, 25, and 10-17 kD (Fig. 3) . Recombinant human TNF-a eluted at 50-55 kD under identical conditions. Experiments were conducted to determine if that monokine was one of the chemokinetic agents in human milk. Direct cytotoxic effects of human milk upon murine L-929 cells were blocked by the rabbit antibodies to recombinant human TNF-a (Fig. 4) . These same antibodies significantly decreased the chemokinetic activity of human milk whey proteins (Fig. 5) and of the fractions of milk obtained by gel filtrations (data not shown). In addition, recombinant human TNF-a was chemokinetic for human blood monocytes, and that effect was blocked completely by the rabbit polyclonal antibodies to recombinant human TNF-a (14 film]) (Fig. 5 ). We were, however, unable to demonstrate TNF-a in human milk by Western blotting.
We examined the possibility that the TNF-cv effect was mediated by IL-1 activity in human milk (24) 
DISCUSSION
Previously, we demonstrated that HMM moved more rapidly than peripheral blood monocytes in a collagen gel system (1 5). In this study, we investigated the genesis of the activation of macrophages in human milk. It appeared that the enhanced motility was not due to activation of the monocytes by factors in the blood of lactating women, but to agents in human milk. Acellular milk was found to be chemokinetic for blood monocytes and the activity did not appear to be due to lipopolysaccharides because those endotoxins are quite heat stable. In contrast the chemokinetic effect of human milk was abolished by heating (56" C for 20 min). The chemokinetic agents were trypsin-sensitive, acid resistant proteins whose M, were between 10-60 kD. Three peaks of chemokinetic activity corresponding to 50-60, 25, and 10-17 kD were found by gel filtration. We subsequently found evidence that part of the chemokinetic activity in human milk may be due to human TNF-a, a monokine that is well known for its cytotoxic (25) (26) (27) (28) (29) (30) , immunomodulating (3 1-38) , and metabolic effects (39) (40) (41) . Although that monokine has not been demonstrated previously in human milk, the partial blocking of the cytotoxicity of human milk by antibodies to TNF-a suggested that TNF-a, or a protein that immunologically cross-reacted with it, was present in human milk. TNF-a (41), along with the potential IL-1 activity in human milk (24) , may account for the well known pyrogenicity of human milk. We demonstrated that part of the chemokinetic activity in human milk was also blocked by anti-TNF-a and that recombinant human TNF-a was chemokinetic for human monocytes. Thus, TNF-a may aid in the recruitment of monocytes.
Despite the evidence for the presence of TNF-a in human milk and the possibility that the 50-60 and the 10-20 kD peaks of chemokinetic activity correspond to the trimeric and monomeric forms of TNF-a, respectively (42), we were unable to demonstrate this monokine in human milk by Western blotting augmented by biotinylation. This may be because the concentrations of TNF-a in human milk are below the limits that can be detected by that method. In a companion study (Mushtaha AA, Schmalstieg FC, Hughes TK Jr, Rudloff HE, Goldman AS, unpublished data), as little as 0.7 pg/pl of recombinant human TNF-a was found to be chemokinetic. This is in keeping with a recent report that TNF-a is chemotactic for polymorphonuclear leukocytes and monocytes (43) . Although the concommitant use of GM-colony stimulating factor in that study was a confounding variable because that agent has also been reported to be chemotactic (44) , similar amounts of TNF-a were active in their Boyden chamber assays. It is therefore likely that only small concentrations of TNF-a in human milk (pglpl) would be required to activate monocytes, and such small amounts of that peptide would not be detected by Western blotting.
An alternative possibility is that other activating factors in human milk stimulate the release of TNF-a from monocytes and that TNF-a was responsible for the final chemokinetic effect. This is in keeping with our observations that human IL-I produces a chemokinetic effect through the release of TNF-a from monocytes (Mushtaha AA, Schmalstieg FC, Hughes T K Jr, Rudloff HE, Goldman AS, unpublished observations). Although the chemokinetic activity in human milk was not inhibited by antibodies to IL-1 and others have not found much evidence for IL-1 production or release from human milk macrophages (I 1), IL-I, or other agents that elicit the release of TNF-a from monocytes may still be present in human milk.
It is possible that TNF-a or other chemokinetic agents in human milk may have significant indirect or direct effects upon the recipient infant. We hypothesize that chemokinetic agents in human milk may aid in recruiting macrophages to mucosal sites of the recipient's alimentary tract (45, 46) . It may be particularly important for the infant to receive these chemokinetic agents because of the developmental delay in the motility of blood monocytes in early life (47) (48) (49) (50) . TNF-a in human milk may also exert anti-viral and immunoregulatory effects by stimulating the production of interferon-B1 (36), interferon-B2 (37), and secretory component (38) . This monokine also alters lipid metabolism by inhibiting lipoprotein lipase (39, 40) . Thus, TNF-a, the pre-viously reported IL-1 activity (24), or other chemokinetic agents in human milk may modulate the immunologic defenses and metabolic activities of the alimentary tract and upper airway of the recipient infant. Further studies of the characterization and the in vivo fate and functions of these molecules are planned to explore those possible effects.
